Vitiligo is a skin condition that can affect infants as young as 3 months old. However, it is rare for an infant to be born with vitiligo. Vitiligo is an autoimmune disease that can run in families.

Vitiligo significantly impacts quality of life, with psychosocial challenges more pronounced in individuals with darker skin tones. JAK inhibitors, including ruxolitinib, tofacitinib, and baricitinib, ...

Vitiligo is an autoimmune disorder that causes depigmentation, or a loss of skin pigment, leading to unusually light patches of skin and hair. The condition is relatively common, affecting up to 1.5 ...